Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/71712
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnucha Muenthaisongen_US
dc.contributor.authorBoondarika Namboopphaen_US
dc.contributor.authorAmarin Rittipornlertraken_US
dc.contributor.authorPallop Tankaewen_US
dc.contributor.authorThanya Varinraken_US
dc.contributor.authorKorkiat Muangthaien_US
dc.contributor.authorKheemchompu Atthikanyaphaken_US
dc.contributor.authorTakuo Sawadaen_US
dc.contributor.authorNattawooti Sthitmateeen_US
dc.date.accessioned2021-01-27T04:05:36Z-
dc.date.available2021-01-27T04:05:36Z-
dc.date.issued2020-01-01en_US
dc.identifier.issn20420048en_US
dc.identifier.other2-s2.0-85087077463en_US
dc.identifier.other10.1155/2020/3548973en_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85087077463&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/71712-
dc.description.abstract© 2020 Anucha Muenthaisong et al. Hemorrhagic septicemia (HS) is an important infectious disease in cattle and buffaloes, caused by Pasteurella multocida B:2 and E:2. The intranasal recombinant OmpH-based vaccine was successfully used to protect dairy cattle from HS in a previous study. Thus, this study aimed to examine the protective ability of that vaccine among buffaloes. Four groups of Thai swamp buffaloes received different vaccines and were labeled as 100 or 200 μg of the rOmpH with CpG-ODN2007, commercial HS bacterin vaccine, and nonvaccinated control groups. Sera and whole blood were collected to examine the antibody levels and cellular immune response using indirect ELISA and MTT assay, respectively. Challenge exposure was performed with virulent P. multocida strain M-1404 serotype B:2 on day 72 of the experiment. The antibody titers to P. multocida among immunized buffaloes were significantly higher than in the control group (p<0.01), especially the 200 μg of the rOmpH group. The stimulation index (SI) of the intranasally vaccinated groups revealed significantly higher levels than the nonvaccinated group (p<0.01), but not different from the intramuscularly commercial HS vaccine. The clinical signs and high fever were observed after challenge exposure in the nonvaccinated group, while it was not observed among the 200 μg of rOmpH immunized buffaloes. The other immunized groups showed partial protection with transient fever. In conclusion, the rOmpH-based intranasal vaccine could elicit protective ability and induce antibody-and cell-mediated immune response against virulent P. multocida strain among swamp buffaloes.en_US
dc.subjectVeterinaryen_US
dc.titleAn Intranasal Vaccination with a Recombinant Outer Membrane Protein H against Haemorrhagic Septicemia in Swamp Buffaloesen_US
dc.typeJournalen_US
article.title.sourcetitleVeterinary Medicine Internationalen_US
article.volume2020en_US
article.stream.affiliationsNippon Veterinary and Life Science Universityen_US
article.stream.affiliationsThailand Ministry of Agriculture and Cooperativesen_US
article.stream.affiliationsChiang Mai Universityen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.